Target discovery and drug development rely heavily on 2D cell and animal models to decipher efficacy and toxic effect of drug candidates. Yet, 90% of candidates fail to make it past phase III…
Introduction – the problem. The average cost of bringing a new drug to the clinic is around $1 billion according to a study…
As we enter the era of sophisticated drug discovery with gene therapy and personalized medicine, we need to be prepared to study…
At Molecular Devices, we cultivate a culture where associates around the world are encouraged to bring their full, authentic selves to…